U.S. Tech Hardware Stock News

XPO (NYSE:XPO) was named to Fortune's 2026 list of the World's Most Admired Companies. The company is the only pure-play North American less than truckload transportation provider on the list. The recognition focuses on XPO's standing among business executives and the financial community. XPO enters this recognition period with its shares at $149.6 and a very large 3 year return and 5 year return, alongside a value score of 2. Over the past 30 days the stock shows a 6.8% return and a 7.8%...

Why Flowserve (FLS) is on investors’ radar Flowserve (FLS) has drawn attention recently as investors look at its share performance alongside current fundamentals, including annual revenue of US$4.69b and net income of US$452.78m, to assess whether the current price still looks reasonable. See our latest analysis for Flowserve. At a share price of US$78.60, Flowserve’s recent momentum stands out, with a 30 day share price return of 10.33% and a 90 day share price return of 47.19%. The 5 year...

USA Rare Earth (NasdaqGM:USAR) plans to build what it describes as Europe's first integrated rare earth metal and alloy production facility in Lacq, France, with financial and operational backing from the French government. The company is also bringing forward its timeline for commercial production at the Round Top rare earth and critical minerals project in Texas by two years. Together, the France facility and the accelerated Texas mine plans are intended to support a more secure and...

If you are trying to figure out whether PTC Therapeutics is genuinely good value or just riding biotech sentiment, it helps to line up the price against what the underlying business may be worth. The stock most recently closed at US$76.17, with returns of 0.7% over 7 days, a 2.0% decline over 30 days, a 0.7% decline year to date, and a 64.9% gain over 1 year, 65.6% over 3 years, and 35.1% over 5 years. Together, these figures can signal shifting views on its risk and reward profile. Recent...

Earlier in January 2026, Praxis Precision Medicines appointed world-renowned neurologist and epilepsy expert Dr. Orrin Devinsky as its new Head of Clinical Strategy, a role that will shape clinical development, evidence generation, and global medical affairs as its late-stage portfolio progresses toward potential commercialization. By bringing in the physician-scientist who helped drive landmark cannabidiol approvals in severe epilepsies and founded multiple influential epilepsy...

Southern (SO) is back in focus after FORTUNE ranked it the No. 1 company in the electric and gas utilities industry, highlighting its reputation, financial soundness, and large-scale infrastructure investment plans. See our latest analysis for Southern. Despite the recent recognition and long term investment plans, Southern’s share price has been fairly muted, with a 1 month share price return of 1.3% and a 90 day share price decline of 8.7%, while the 1 year total shareholder return of 9.9%...

Cardinal Health (NYSE:CAH) is expanding national hospital access to Rapiblyk, a critical care drug, through its distribution network alongside other major distributors. The broader availability is intended to reach hospitals and health systems across the United States. This development extends Cardinal Health's role in supplying therapies used in high-acuity hospital settings. For you as an investor, this move sits at the core of Cardinal Health's role as a large pharmaceutical and medical...

If you are wondering whether Integer Holdings is priced attractively right now, the key question is how its current share price compares with what the business might be worth. The stock last closed at US$85.54, with returns of 0.3% over 7 days, 10.0% over 30 days, 11.4% year to date, 19.1% over 3 years and 11.2% over 5 years, set against a 40.3% decline over the last year. Recent news flow around Integer Holdings has focused on broader coverage of the medical device sector and investor...

Why Jazz Pharmaceuticals is back on investors’ radar Boehringer Ingelheim’s new clinical collaboration with Jazz Pharmaceuticals (JAZZ), pairing zongertinib with zanidatamab for HER2-positive breast cancer, is drawing fresh attention to Jazz’s oncology pipeline and its broader stock story. See our latest analysis for Jazz Pharmaceuticals. Jazz’s shares have been relatively flat in the very short term, but a 23.44% 90 day share price return alongside a 40.12% one year total shareholder return...

Why Restaurant Brands International Is On Investors’ Radar Restaurant Brands International (QSR) has drawn interest after recent share price moves, with the stock showing mixed short term returns while maintaining a positive trend over the past 3 years and 5 years. See our latest analysis for Restaurant Brands International. Recent trading has been choppy, with a 7 day share price return of 1.41% decline and a 90 day share price return of 1.68% gain. However, the 1 year total shareholder...

In January 2026, Zscaler, Inc. appointed Dr. Swamy Kocherlakota as Executive Vice President of Agentic AI Security Engineering to lead its response to emerging autonomous AI agent risks and expand the Zscaler Zero Trust Exchange™. This hire signals a push to address AI security at the architectural level, positioning Zscaler to serve developers and business leaders confronting complex new cyberthreats. We’ll now look at how this focus on securing autonomous AI agent workflows could shape...

If you are wondering whether Mirion Technologies' current share price reflects its long term potential, you are not alone. Valuation is front and center for many investors right now. After a recent close at US$26.69, the stock has seen a 1.1% decline over the last week, an 11.8% gain over the last 30 days, a 12.0% gain year to date, a 46.0% gain over the last year and a very large gain over the last 3 years, with a 132.9% gain over 5 years adding extra context for longer term holders. Recent...

On 22 January 2026, Triumph announced that J.B. Hunt Transport Services, Inc. joined the Triumph Network and will use its automated payment solution to speed up and simplify carrier payment cycles. The agreement brings a major freight operator onto Triumph’s platform, underscoring how its payment tools are being adopted to build efficiency and trust across the freight ecosystem. Next, we’ll examine how partnering with J.B. Hunt on automated freight payments could influence Triumph...

Lam Research (NasdaqGS:LRCX) is reporting results that are ahead of earnings expectations as a new semiconductor supercycle builds around AI infrastructure and advanced memory. The company is integrating AI into its own manufacturing processes, aiming to improve equipment performance and factory efficiency. Lam is positioned to benefit from industry catalysts such as the U.S. CHIPS Act and customer transitions toward 2nm production nodes. Lam Research sits at the center of equipment demand...

In late January 2026, Steel Dynamics prepared to report quarterly results that analysts expected to show higher earnings per share and revenue compared with a year earlier, with consensus forecasts revised upward in recent weeks. This shift in analyst expectations highlighted how the company’s balance of shareholder returns and growth investment is influencing perceptions of its earnings power. Next, we’ll examine how these upgraded earnings expectations shape Steel Dynamics’ investment...

In recent weeks, Northrop Grumman has secured several new U.S. Navy and Marine Corps contracts, including a US$233 million advanced lightweight torpedo program and a US$94.3 million second-stage solid rocket motor award, while analysts project higher upcoming quarterly earnings and revenue compared with the same period last year. Together with its selection for the Marine Corps’ MUX TACAIR Collaborative Combat Aircraft program, these wins underline Northrop Grumman’s expanding role in...

Multiple securities class action lawsuits and legal investigations have been filed against CoreWeave (NasdaqGS:CRWV). Claims focus on whether the company misled investors about its capacity to meet customer demand and its dependence on a single third party data center supplier. The cases question past disclosures on operational risks and expansion plans that may be material to shareholders. CoreWeave, trading on NasdaqGS under the ticker CRWV, closed at $91.79. The share price reflected a...

Dynex Capital director Joy Palmer will not stand for re election to the Board at the upcoming Annual Meeting. Her departure will create a change in board composition and governance oversight at Dynex Capital, NYSE:DX. For investors watching Dynex Capital, NYSE:DX, the board update arrives with the stock at a share price of $14.44. Over the past year, the company shows a 34.0% return, and over 3 years a 47.7% return, with a 41.8% return over 5 years. In the shorter term, the stock shows a...

Joby Aviation (JOBY) is back in focus after cautious commentary tempered earlier enthusiasm around its electric air taxi rollout, even as the company reports early revenue, expanded manufacturing, and progress toward FAA certification and planned Dubai operations. See our latest analysis for Joby Aviation. Joby’s share price has been choppy, with a 1 day share price return of 1.68% and a 7 day share price return showing a 4.84% decline. A 1 year total shareholder return of 67.70% and a 3 year...

If you are wondering whether Tyson Foods at around US$61.12 a share offers value or just noise, you are not alone. That is exactly what this article aims to unpack for you. Over the short term, Tyson Foods has posted returns of 1.1% over 7 days, 5.8% over 30 days, 5.3% year to date and 12.9% over the last year, with a 3.6% return over 3 years and 9.5% over 5 years that some investors may compare with their expectations and risk tolerance. Recent news coverage around Tyson Foods has focused...

StepStone Group (STEP) is back in focus after leading Upscale AI’s $200 million Series A round in AI networking infrastructure, alongside a new senior housing continuation vehicle with Blue Moon Capital Partners. See our latest analysis for StepStone Group. The recent Upscale AI financing and senior housing vehicle arrive as StepStone’s share price sits at US$75.39, with a 30 day share price return of 13.40% and a 90 day share price return of 19.16%, alongside a 3 year total shareholder...

Accenture (NYSE:ACN) has been selected by Sovereign AI to help build and scale sovereign-grade AI data centers across Europe, the Middle East, and Africa. Palantir Technologies will provide software for the initiative, while Accenture contributes its digital and AI infrastructure expertise. The collaboration focuses on secure, resilient AI capabilities for both governmental and commercial clients in the EMEA region. For you as an investor, this ties directly to what Accenture already does...

If you are wondering whether Arthur J. Gallagher’s current share price reflects its true business value, you are not alone. This article will walk you through the key numbers that matter. The stock last closed at US$250.38, with returns of a 2.3% decline over 7 days, a 3.2% decline over 30 days, a 2.2% decline year to date and a 12.3% decline over the past year, compared to gains of 30.5% over 3 years and 128.6% over 5 years. Recent coverage has focused on Arthur J. Gallagher’s position as a...

Why Carvana’s Upcoming Earnings Matter Now Carvana (CVNA) is back in focus as analysts reiterate positive views, consensus recommendations trend higher, and recent results point to improving earnings, sales growth, better margins, and consistent revenue outperformance. See our latest analysis for Carvana. Those upbeat earnings expectations and recent analyst actions have arrived alongside strong share price momentum, with Carvana’s 90 day share price return of 36.23% contributing to a 19.54%...